Selective cyclooxygenase inhibitors: Novel 4-spiro 1,2-diarylcyclopentenes are potent and orally active cox-2 inhibitors

David B. Reitz, Horng Chih Huang, James J. Li, Danny J. Garland, Robert E. Manning, Gary D. Anderson, Susan A. Gregory, Carol M. Koboldt, William E. Perkins, Karen Seibert, Peter C. Isakson

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Selective cyclooxygenase inhibitors: Novel 4-spiro 1,2-diarylcyclopentenes are potent and orally active cox-2 inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds